RECRUITING

A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care

Conditions

Depression, Postpartum Efficacy, Self Anxiety

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess the effectiveness of a parenting intervention+usual care compared to usual care on postpartum depression and other mental health and parenting outcomes, as well as the feasibility and acceptability of the parenting intervention.

Official Title

A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care (MInD)

Quick Facts

Study Start:2022-11-01

Study Completion:2025-06-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT04998721

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* English speaking pregnant women between gestational age (GA) 13 - 24 weeks * ≥ 18 years, * EPDS score ≥10, * Ability to send and receive text messages (TM)	* Severe substance use disorder in the past 6 months (score of 4 or above on the Alcohol Use Disorders Test AUDIT-C or a score of 6 or more on the Drug Abuse Screening Test (DAST). * Active suicidal ideation as measured by follow up to a positive answer to question 10 on the EPDS. * Bipolar disorder (Composite International Diagnostic Interview score ≥7) or psychotic disorder (assessed by chart review); * Multiple gestation (assessed by self-report and medical record); * Ongoing active treatment with psychotropic medications by mental health specialist (but not a PCP or Obstetrician).

Inclusion Criteria

Exclusion Criteria

* English speaking pregnant women between gestational age (GA) 13 - 24 weeks
* ≥ 18 years,
* EPDS score ≥10,
* Ability to send and receive text messages (TM)

* Severe substance use disorder in the past 6 months (score of 4 or above on the Alcohol Use Disorders Test AUDIT-C or a score of 6 or more on the Drug Abuse Screening Test (DAST).
* Active suicidal ideation as measured by follow up to a positive answer to question 10 on the EPDS.
* Bipolar disorder (Composite International Diagnostic Interview score ≥7) or psychotic disorder (assessed by chart review);
* Multiple gestation (assessed by self-report and medical record);
* Ongoing active treatment with psychotropic medications by mental health specialist (but not a PCP or Obstetrician).

Contacts and Locations

Study Contact

Amritha Bhat, MD

CONTACT

2065433117

amritha@uw.edu

Jamie Adachi, MPH

CONTACT

jadachi@uw.edu

Principal Investigator

Amritha S Bhat, MD, MPH

PRINCIPAL_INVESTIGATOR

University of Washington

Study Locations (Sites)

Amritha Bhat

Seattle, Washington, 98195

United States

Collaborators and Investigators

Sponsor: University of Washington

Amritha S Bhat, MD, MPH, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-01

Study Completion Date2025-06-01

Study Record Updates

Study Start Date2022-11-01

Study Completion Date2025-06-01

Terms related to this study

Additional Relevant MeSH Terms

Depression, Postpartum
Efficacy, Self
Anxiety